Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Enteromycetin Otic** is a fixed-dose otic ear-drop product marketed by Dey's Medical Stores for bacterial outer-ear infections and associated ear pain. It contains **benzocaine** and **chloramphenicol**: chloramphenicol is a broad-spectrum antibacterial agent that inhibits bacterial protein synthesis through binding to the bacterial 50S ribosomal subunit, while benzocaine is a local anesthetic that reduces pain by blocking neuronal sodium-channel-mediated impulse conduction. The product is intended for topical administration into the ear canal.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Enteromycetin Otic.